Publications by authors named "Solene De Boisvilliers"
Article Synopsis
- RSV significantly impacts infants in Spain, leading to many healthcare visits and high costs during their first RSV season.
- A decision-analytic model showed that using nirsevimab as a preventive treatment for all infants could dramatically reduce RSV-related health events and hospitalizations, compared to standard practices.
- Immunizing with nirsevimab could prevent over 97,000 outpatient visits and save about €47.8 million in healthcare costs, highlighting its potential as a cost-effective public health strategy.
Background: Limited data are available describing the global impact of COVID-19 vaccines. This study estimated the global public health and economic impact of COVID-19 vaccines before the emergence of the Omicron variant.
Methods: A static model covering 215 countries/territories compared the direct effects of COVID-19 vaccination to no vaccination during 13 December 2020-30 September 2021.
Background: As the body of evidence on COVID-19 and post-vaccination outcomes continues to expand, this analysis sought to evaluate the public health impact of the Pfizer-BioNTech COVID-19 Vaccine, BNT162b2, during the first year of its rollout in the US.
Methods: A combined Markov decision tree model compared clinical and economic outcomes of the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) versus no vaccination in individuals aged ≥12 years. Age-stratified epidemiological, clinical, economic, and humanistic parameters were derived from existing data and published literature.